Literature DB >> 3759084

Polysomy of chromosome 7 is correlated with overexpression of the erbB oncogene in human glioblastoma cell lines.

W Henn, N Blin, K D Zang.   

Abstract

Chromosome analysis in a series of human glioblastoma cell lines (HeRo, HeRo-SV1, A172, T406, T508, T705) has indicated characteristic changes in the karyotype, the most striking and consistent of which is a significant increase in the copy number of chromosome 7, with up to 8 copies per metaphase. As determined by Spurr et al., chromosome 7 represents the genomic locus for the oncogene erbB (7pter-q22). Therefore, we have compared the number of chromosomes 7 to the levels of expression of the erbB oncogene. Interestingly, in all of them erbB-specific mRNA was found to be increased at levels even higher than expected from the number of chromosomes 7 found. In contrast, in an astrocytoma of slightly lower grade of malignancy (cell line T567), neither polysomy 7 nor significant expression of the erbB oncogene was noted.

Entities:  

Mesh:

Year:  1986        PMID: 3759084     DOI: 10.1007/bf00278796

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  12 in total

1.  Establishment and characterization of a human glioblastoma cell line with a stable karyotype and nullisomy 13.

Authors:  H Fischer; K Schwechheimer; M Heider; S Bernhardt; K D Zang
Journal:  Cancer Genet Cytogenet       Date:  1985-07

2.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

3.  Banding patterns in human glioma cell lines.

Authors:  J Mark; B Westermark; J Pontén; R Hugosson
Journal:  Hereditas       Date:  1977       Impact factor: 3.271

4.  Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma.

Authors:  H Koprowski; M Herlyn; G Balaban; A Parmiter; A Ross; P Nowell
Journal:  Somat Cell Mol Genet       Date:  1985-05

5.  Rat insulin genes: construction of plasmids containing the coding sequences.

Authors:  A Ullrich; J Shine; J Chirgwin; R Pictet; E Tischer; W J Rutter; H M Goodman
Journal:  Science       Date:  1977-06-17       Impact factor: 47.728

6.  Genetic analysis of hyperproduction of epidermal growth factor receptors in human epidermoid carcinoma A431 cells.

Authors:  N Shimizu; I Kondo; S Gamou; M A Behzadian; Y Shimizu
Journal:  Somat Cell Mol Genet       Date:  1984-01

7.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

Authors:  D J Giard; S A Aaronson; G J Todaro; P Arnstein; J H Kersey; H Dosik; W P Parks
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

8.  The nucleotide sequence of the rat cytoplasmic beta-actin gene.

Authors:  U Nudel; R Zakut; M Shani; S Neuman; Z Levy; D Yaffe
Journal:  Nucleic Acids Res       Date:  1983-03-25       Impact factor: 16.971

9.  Chromosomal localisation of the human homologues to the oncogenes erbA and B.

Authors:  N K Spurr; E Solomon; M Jansson; D Sheer; P N Goodfellow; W F Bodmer; B Vennstrom
Journal:  EMBO J       Date:  1984-01       Impact factor: 11.598

10.  Isolation and characterization of multiple human genes homologous to the oncogenes of avian erythroblastosis virus.

Authors:  M Jansson; L Philipson; B Vennström
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  14 in total

Review 1.  Genetic markers on chromosome 7.

Authors:  L C Tsui
Journal:  J Med Genet       Date:  1988-05       Impact factor: 6.318

2.  Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes.

Authors:  T Cremer; P Lichter; J Borden; D C Ward; L Manuelidis
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

3.  Proliferation enhancement by spontaneous multiplication of chromosome 7 in rheumatic synovial cells in vitro.

Authors:  A Ermis; W Henn; K Remberger; C Hopf; T Hopf; K D Zang
Journal:  Hum Genet       Date:  1995-12       Impact factor: 4.132

4.  Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system.

Authors:  G Reifenberger; R Prior; M Deckert; W Wechsler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  Epidermal growth factor receptor targeted nuclear delivery and high-resolution whole cell X-ray imaging of Fe3O4@TiO2 nanoparticles in cancer cells.

Authors:  Ye Yuan; Si Chen; Tatjana Paunesku; Sophie Charlotte Gleber; William C Liu; Caroline B Doty; Rachel Mak; Junjing Deng; Qiaoling Jin; Barry Lai; Keith Brister; Claus Flachenecker; Chris Jacobsen; Stefan Vogt; Gayle E Woloschak
Journal:  ACS Nano       Date:  2013-11-27       Impact factor: 15.881

Review 6.  Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment.

Authors:  R Radinsky
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

7.  Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses.

Authors:  C A Kruse; D H Mitchell; B K Kleinschmidt-DeMasters; W A Franklin; H G Morse; E B Spector; K O Lillehei
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

8.  Karyotype analyses of 20 human glioma cell lines.

Authors:  M Westphal; M Hänsel; W Hamel; R Kunzmann; F Hölzel
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

9.  Trisomy 7 in synovial fluid cells of patients with rheumatoid arthritis.

Authors:  Funda Tascioglu; Beyhan Durak; Cengiz Oner; Sevilhan Artan
Journal:  Rheumatol Int       Date:  2004-06-25       Impact factor: 2.631

10.  Amplification of the c-erbB oncogene is associated with malignancy in primary tumours of neuroepithelial tissue.

Authors:  U Diedrich; S Soja; J Behnke; B Zoll
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.